Rajesh Malik
CIK 1706853 · Chief Medical Officer · last filed 2024-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
47
Lifetime Open-Market Net
-$3.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. (GTHX) Delisted | Chief Medical Officer | 177,212 | $7.15 | $1.27M | -$3.94M | 42 | 2024-09-18 |
| POINT Biopharma Global Inc. (PNT) Delisted | Director | 0 | $12.50 | $0 | $24.6K | 5 | 2023-12-27 |
Recent Filings · Page 3 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-23 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$325.2K | EDGAR |
| 2021-03-24 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$323.2K | EDGAR |
| 2021-03-04 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$321.0K | EDGAR |
| 2021-01-29 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +3,100 | $1.2K | EDGAR |
| 2021-01-22 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$247.0K | EDGAR |
| 2021-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2020-12-11 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$143.0K | EDGAR |
| 2020-03-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +2,500 | $975 | EDGAR |
| 2020-02-07 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-24 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +5,000 | $1.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.